University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to ...

Neuraxpharm introduced Midazolam buccal as an anti-epileptic drug meant to treat status epilepticus. The buccal mucosal delivery of Midazolam provides a convenient and fast-absorbing method for ...

Investorideas , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors ...

The University of Virginia (UVA) is spearheading a nationwide clinical trial exploring a new treatment option for prolonged seizures.

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...

Patna: International Epilepsy Day, observed on the second Monday of Feb since 2015, aims to educate the public, break the ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Viehbacher, "Biogen") announced today that the U.S. Food and Drug Administration (FDA ... including seizure and status epilepticus, can occur. ARIA can be fatal. Serious intracerebral hemorrhages (ICH ...

Contribute to manasi4231/Market-Network development by creating an account on GitHub.

This article discusses some of the issues related to protocols for emergency anticonvulsant treatment of acute seizures and status epilepticus with particular ... by the prompt administration of ...